The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Is this intended as a joke - referring to Sunrise Resources plc as one of the "Major players in the global pozzolan market"?
Sunrise and PC couldn't run an ice-cream stall on a summer's day by the seaside
By the way, the telephone number for Gamblers Anonymous is 0330 094 0322
I like that - " ...we have recently acquired..." haha
PC is living proof that you can fool quite a lot of people all of the time
I could go back to 2009 and the failed barite project (https://www.proactiveinvestors.co.uk/companies/news/23787/sunrise-resources-gets-positive-concept-study-for-derryginagh-barite-project-in-ireland-28393.html). Ad all along it has been a sad and sorry story for the shareholders. But hey - not to worry - because PC travels the world and will have a fine pension pot at the end of it all.
Oh - and Tertiary (TYM) is very relevant here since both it and SRES are controlled by PC. You may or may not be aware, but SRES and ALL its "assets" was once within TYM but PC decided to spin it off as a separate entity. And so Sunrise was born. A new dawn!
You are omitting a whole litany of other failures ... not to mention the trail of disasters he has left behind him at the sister company Tertiary Minerals (TYM)
Hear! Hear!
Over on the "other" website its the same thing ... any word of caution was met with abuse. There is one poor innocent there (he may have been an air pilot!) who really seemed to believe that his ship was going to come in with SRES - a racing certainty that would make his fortune. Its pathetic how poor uneducated people like that are sucked in by little Mickey Mouse "enterprises" like Sunrise and PC who has a rotten track record and has left a trail of failed projects in his wake. I hope the "pilot" doesn't have a family to support - rather than pouring money down the drain, i.e. into PC's pension fund. He might stand a better chance at the bookies but, on 2nd thoughts, that would also be disastrous as he would most likely always opt for the 150/1 outsiders.
And no question, SRES and their sister parasite company should be wound up.
On the basis that "there's many a slip 'twixt the cup and the lip", I will defer gloating for another few weeks - at least.
That's a tricky one for you Tricky64 - but I think you will have a hard job not letting them go at this price! If you find a way of holding onto them for a better price, do let us know!
Genmab - a Danish biotech company is worth watching. It has a licence agreement with Janssen (a Johnson & Johnson subsidary) for the development of daratumumab - an antibody treatment for multiple myeloma. The drug is in Phase 3 trials at present and yesterday (Oct 23) it was announced that Genmab are to receive a $10 million milestone payment "triggered by progress in the phase III study of daratumumab in combination with bortezomib and dexamethasone." The payment was anticipated in Genmab's financial guidance for the year. The actual payment indicates the progress is on track. The FDA has granted "breakthrough therapy" designation to daratumumab which could accelerate its development and availability to the market. Genmab has a small share issue and postive news on this could move the share proce significantly. I am a holder.